Senator Todd Young on China, FDA Reform, and Why Biotech Is National Security

Biotech is no longer just about medicine. It is now a frontline issue in national security, global competition, and economic independence.In this episode of the Making Medicine Podcast, Senator Todd Young joins us to break down the growing risks of relying on China for critical biotech inputs, why FDA speed and regulatory clarity matter more than ever, and how the US can stay competitive in a rapidly shifting global landscape.From supply chain vulnerabilities to AI-driven drug development, this conversation explores the intersection of policy, innovation, and national defense. Senator Young also shares insights on drug pricing, biotech investment, and why strengthening the full ecosystem from startups to large manufacturers is critical for long-term US leadership.If the US fails to act, the consequences go far beyond healthcare. They shape who leads the next century of innovation.At stake is not just faster cures, but whether America remains the global leader in biotech or falls behind.Join the Conversation ⬇️Should the US decouple biotech supply chains from China?Can the FDA move faster without sacrificing safety?What policy change would most strengthen US biotech leadership?Drop your thoughts in the comments below 👇If you're new to the Making Medicine Podcast, we're happy you're here!Follow us for more:https://x.com/MakingMedPodhttps://www.instagram.com/makingmedicinepod/https://www.linkedin.com/showcase/making-medicine-podcast/about/?viewAsMember=trueTime Stamps00:00 Intro and disclaimer00:17 Senator Young on China dependency risk00:33 Meet Senator Todd Young01:53 Why biotech is national security03:23 Biotech’s role in defense, materials, and Department of War04:17 Supply chain resiliency and China risk05:16 Biotech threats, food security, and countermeasures06:41 China, biotech standards, and global competition08:04 Why innovators go abroad for speed and cost08:46 FDA optimization, AI, and faster drug development12:16 Indiana’s biotech ecosystem and Eli Lilly16:32 Why small biotech and big pharma need each otherDISCLAIMER: We’re reporting on the headlines, not making medical recommendations. For personal health questions, always consult a doctor.#biotech #FDA #China #nationalsecurity #pharma #healthpolicy #innovation #senatortoddyoung